Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Luciana M. Herda"'
Autor:
Martina Tuttolomondo, Cinzia Casella, Pernille Lund Hansen, Ester Polo, Luciana M. Herda, Kenneth A. Dawson, Henrik J. Ditzel, Jan Mollenhauer
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 8, Iss , Pp 264-276 (2017)
Small interfering RNA (siRNA) is a promising molecule for gene therapy, but its therapeutic administration remains problematic. Among the recently proposed vectors, cell-penetrating peptides show great promise in in vivo trials for siRNA delivery. Hu
Externí odkaz:
https://doaj.org/article/36b35a8d38e34540a4cf108f20b942a8
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-10 (2016)
The protein corona on nanoparticle surfaces leads to presentation of receptor-binding motifs and defines the cellular interactions. Here, the authors use antibody mapping fluorescent quantum dot reporters, and flow cytometry to measure the availabili
Externí odkaz:
https://doaj.org/article/b8998288c6df4bde9b7a9d494f30b769
Autor:
Sandra Lara, André Perez-Potti, Laurent Adumeau, Yan Yan, Luciana M. Herda, Kenneth A. Dawson
Publikováno v:
ACS Nano. 12:4930-4937
Key practical challenges such as understanding the immunological processes at the nanoscale and controlling the targeting and accumulation of nano-objects in vivo now further stimulate efforts to underpin phenomenological knowledge of the nanoscale w
Autor:
Kenneth A. Dawson, Henrik J. Ditzel, Jan Mollenhauer, Ester Polo, Luciana M. Herda, Martina Tuttolomondo, Pernille Lund Hansen, Cinzia Casella
Publikováno v:
Tuttolomondo, M, Casella, C, Hansen, P L, Polo, E, Herda, L M, Dawson, K A, Ditzel, H J & Mollenhauer, J 2017, ' Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery ', Molecular Therapy-Nucleic Acids, vol. 8, pp. 264-276 . https://doi.org/10.1016/j.omtn.2017.06.020
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 8, Iss, Pp 264-276 (2017)
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 8, Iss, Pp 264-276 (2017)
Small interfering RNA (siRNA) is a promising molecule for gene therapy, but its therapeutic administration remains problematic. Among the recently proposed vectors, cell-penetrating peptides show great promise in in vivo trials for siRNA delivery. Hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc49468ffcfb2e1a7cf2c3cd3346a498
https://findresearcher.sdu.dk:8443/ws/files/128562324/Human_DMBT1_Derived_Cell_Penetrating_Peptides_for_Intracellular_siRNA_Delivery.pdf
https://findresearcher.sdu.dk:8443/ws/files/128562324/Human_DMBT1_Derived_Cell_Penetrating_Peptides_for_Intracellular_siRNA_Delivery.pdf
Autor:
Kenneth A. Dawson, Luciana M. Herda, Maria Cristina Lo Giudice, Delyan R. Hristov, Ester Polo
Characterizing the orientation of covalently conjugated proteins on nanoparticles, produced for in vitro and in vivo targeting, though an important feature of such a system, has proved challenging. Although extensive physicochemical characterization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c072a2c0ee15a745c027339a8051d8
Publikováno v:
European Journal of Nanomedicine. 6
Access of therapeutic agents to the central nervous system is generally restricted by an intricate barrier system, which protects the brain and maintains homeostasis. Endogenous nutrients, however, engage with the available molecular systems and succ